News

Merck exec says Chernobyl changed the course of her life after her father begged her to leave nuclear physics on his deathbed
Gen Z grads are slamming degrees as worthless—but Fortune 500 boss, Doina Ionescu, says her MBA was the best investment ...
The Motley Fool: Merck’s risks and potential
There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...
Exclusive: Kennedy's new vaccine adviser was expert witness against Merck vaccine
One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an ...
RFK Jr.’s New Vaccine Panel Includes Two Paid Witnesses Against Merck
Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert ...
Cantor Keeps Merck (MRK) at Neutral Amid Gardasil Dosage Review By ACIP.
Merck & Co., Inc. (NYSE:MRK) is one of the 15 best stocks to invest in for an 18 year old. On June 10, Cantor Fitzgerald ...
Explore more
Dow falls nearly 300 points on losses for shares of Nike, Merck
The Dow Jones Industrial Average is down Tuesday afternoon with shares of Nike and Merck facing the biggest losses for the blue-chip average.
Dow's nearly 150-point drop led by losses for Nike, Merck shares
Dragged down by declines for shares of Nike and Merck, the Dow Jones Industrial Average is falling Tuesday afternoon.
Citizens Financial, Merck, oil producers: Trending Tickers
Citizens Financial Group (CFG) will be expanding its share buyback program to $1.5 billion. Pharmaceutical giant Merck (MRK) ...
Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
Merck's Keytruda receives FDA approval for head and neck cancer after showing improved event-free survival in Phase 3 KEYNOTE ...
Profits of Doom: Why Investors Seem to Shrug Off War
The Israel-Iran clash seemingly has no end in sight — a prospect that does not seem to be panicking the markets.
Healio2h
VIDEO: Pembrolizumab, lenvatinib combo shows promise in clear-cell ovarian carcinoma
In this video, Susana M. Campos, MD, MPH, discusses results from a phase 2 trial of pembrolizumab and lenvatinib for patients with recurrent or persistent clear-cell ovarian cancer.Findings from the ...